Document Detail

The new cell culture smallpox vaccine should be offered to the general population.
MedLine Citation:
PMID:  12516058     Owner:  NLM     Status:  MEDLINE    
A series of major factors must be weighed in deciding whether or not, and to what extent, a particular country should consider pre-exposure vaccination for smallpox. These include the risk of a bioterrorist attack using smallpox, the risk of secondary spread from another country, the risks and benefits of vaccination, the effectivenes s of vaccination pre- and post-exposure, the prevalence of immunocompromised persons, the capacity of the medical care delivery system and the wealth of a nation. We review here the issues and variables relevant for policy making, propose a framework for country-specific decision making and suggest the World Health Organization has a key role to play, particularly with regard to lower-income countries. In doing so, we support the proposition.
William Bicknell; Kenneth James
Related Documents :
22022448 - Impact of the rts,s malaria vaccine candidate on naturally acquired antibody responses ...
13944288 - Relationship between pock counts on chorio-allantoic membrane and percentages of "takes...
22069498 - Capsomer vaccines protect mice from vaginal challenge with human papillomavirus.
10593568 - Immunization in the first month of life may explain decline in incidence of iddm in the...
2549498 - Humoral immunity and clinical reinfections following varicella vaccine in healthy child...
25093068 - Oae: the ontology of adverse events.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Reviews in medical virology     Volume:  13     ISSN:  1052-9276     ISO Abbreviation:  Rev. Med. Virol.     Publication Date:    2003 Jan-Feb
Date Detail:
Created Date:  2003-01-07     Completed Date:  2003-03-13     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  9112448     Medline TA:  Rev Med Virol     Country:  England    
Other Details:
Languages:  eng     Pagination:  5-15     Citation Subset:  IM    
Copyright Information:
Copyright 2003 John Wiley & Sons, Ltd.
Department of International Health, School of Public Health, Boston University, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Mass Vaccination / methods*
Public Health*
Smallpox / epidemiology,  prevention & control*
Smallpox Vaccine / administration & dosage*,  adverse effects,  immunology,  standards
United States / epidemiology
World Health Organization
Reg. No./Substance:
0/Smallpox Vaccine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Upregulation of expression from the FRDA genomic locus for the therapy of Friedreich ataxia.
Next Document:  The new cell culture smallpox vaccine should not be offered to the general population.